Garry E. Menzel - 17 Nov 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC.

Signature
/s/ Margaret Siegel as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
17 Nov 2022
Net transactions value
$0
Form type
4
Filing time
18 Nov 2022, 15:56:03 UTC
Previous filing
26 Aug 2022
Next filing
05 Dec 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TCRR Common Stock 132,729 17 Nov 2022 See Footnote F1
holding TCRR Common Stock 132,730 17 Nov 2022 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -6,240 -100% $0.000000* 0 17 Nov 2022 Common Stock 6,240 $16.11 Direct F3, F4
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +2,080 $0.000000 2,080 17 Nov 2022 Common Stock 2,080 Direct F4, F5, F6
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -479,866 -100% $0.000000* 0 17 Nov 2022 Common Stock 479,866 $16.11 Direct F3, F7
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +159,956 $0.000000 159,956 17 Nov 2022 Common Stock 159,956 Direct F5, F6, F7
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -3,500 -100% $0.000000* 0 17 Nov 2022 Common Stock 3,500 $16.10 Direct F8, F9
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +1,167 $0.000000 1,167 17 Nov 2022 Common Stock 1,167 Direct F5, F9, F10
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -164,500 -100% $0.000000* 0 17 Nov 2022 Common Stock 164,500 $16.10 Direct F8, F11
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +54,834 $0.000000 54,834 17 Nov 2022 Common Stock 54,834 Direct F5, F10, F11
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -4,512 -100% $0.000000* 0 17 Nov 2022 Common Stock 4,512 $31.83 Direct F12, F13
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +821 $0.000000 821 17 Nov 2022 Common Stock 821 Direct F5, F13, F14
transaction TCRR Stock Option (right to buy) Disposed to Issuer $0 -240,488 -100% $0.000000* 0 17 Nov 2022 Common Stock 240,488 $31.83 Direct F12, F15
transaction TCRR Restricted Stock Unit (right to buy) Award $0 +43,726 $0.000000 43,726 17 Nov 2022 Common Stock 43,726 Direct F5, F14, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 132,729 shares of common stock held by the Garry E. Menzel and Mary E. Henshall Family Trust, under instrument of trust dated July 29, 2010, to the Garry E. Menzel Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Menzel Trust"). The reporting person is the trustee of the Menzel Trust, and as such the reporting person may be deemed to beneficially own such securities. The reporting person and members of his immediate family are the sole beneficiaries of the Menzel Trust.
F2 Consists of 132,730 shares of common stock held by and the Mary E. Henshall Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Henshall Trust"). The reporting person's spouse is the trustee of the Henshall Trust, and as such the reporting person may be deemed to beneficially own such securities. The reporting person and members of his immediate family are the sole beneficiaries of the Henshall Trust.
F3 This cancelled option vested 25% on January 1, 2020 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F4 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on April 11, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 2,080.
F5 Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F6 The restricted stock units will vest 98% on December 1, 2022, and 2% on December 1, 2023.
F7 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on April 11, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 159,956.
F8 This cancelled option vested 25% on January 1, 2021 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F9 On November 17, 2022, the issuer canceled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 19, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 1,167.
F10 73% of these RSUs will vest on December 1, 2022, 25% will vest on December 1, 2023 and the remaining 2% will vest on December 1, 2024.
F11 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 19, 2019. In exchange for such stock option, the reporting person received restricted stock units in the amount of 54,834.
F12 This cancelled option vested 25% on January 1, 2022 and the remaining 75% vests in 36 substantially equal monthly installments thereafter.
F13 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 10, 2020. In exchange for such stock option, the reporting person received restricted stock units in the amount of 821.
F14 48% of these RSUs will vest on December 1, 2022, 25% will vest on December 1, 2023, another 25% will vest on December 1, 2024 and the remaining 2% will vest on December 1, 2025.
F15 On November 17, 2022, the issuer cancelled, pursuant to the issuer's offer to exchange eligible options for new restricted stock units program, a stock option granted to the reporting person on December 10, 2020. In exchange for such stock option, the reporting person received restricted stock units in the amount of 43,726.